Department of Pediatrics, Bharati Vidyapeeth (Deemed to be University) Medical College and Hospital, Pune, Maharashtra, India.
Clinical Pharmacy, Bharati Vidyapeeth (Deemed to be University), Poona College of Pharmacy, Pune, Maharashtra, India.
Eur J Hosp Pharm. 2023 May;30(3):147-152. doi: 10.1136/ejhpharm-2021-002721. Epub 2021 Jun 28.
Guidelines for the management of status epilepticus (SE) aid in rationalising the treatment for a better clinical outcome; however, published literature regarding the use of antiepileptics and compliance is limited, even after the availability of a consensus guideline.
To evaluate the use of antiepileptics in children with SE and to analyse the effect of compliance with the Status Epilepticus Management Protocol on clinical outcomes.
An open-label non-randomised prospective observational study was conducted in children with SE aged 1 month to 14 years for 8 months in a tertiary care teaching hospital. The recommended antiepileptics, sequence of drug administration and time frames of management offered to paediatric patients were assessed for compliance with the Status Epilepticus Management Protocol adopted in our hospital. Comparison of clinical outcomes (hospital stay, intubation, refractory and super-refractory SE, duration of SE cessation, functional motor deficits and cognitive decline) between compliant and non-compliant patients was assessed.
A total of 40 patients were included in the study, of which 28 (70%) were boys. All the patients received midazolam nasal spray in the triage area. Only 18% of the patients received rescue benzodiazepine (BZD) antiepileptic drug (AED) therapy in pre-hospital settings. Median time (p-p) of administration of first-line AED (BZD) and second-line AED (non-BZD) was 11 (8-15) min and 30 (22-35) min, respectively. Administration of continuous infusion (IV midazolam) was delayed at 57 (45-69) min. Compliance with the Status Epilepticus Management Protocol was seen in 24 (60%) patients. Non-compliance with the treatment protocol in relation to the time frame significantly prolonged the length of hospital stay (9 vs 4 days, p=0.0008) and SE duration from first assessment (115 vs 50 min; p=0.005). At discharge, the proportion of patients returning to their functional baseline was significantly different in the compliant and non-compliant patient groups (79% vs 44%). There were no deaths.
Rescue therapy in the pre-hospital setting needs attention. There was full compliance with the Status Epilepticus Management Protocol for choice of AED and sequence of AED therapy. Non-compliance in treatment management within time frames significantly affected the length of hospital stay, duration of SE and clinical outcome.
癫痫持续状态(SE)管理指南有助于规范治疗以获得更好的临床结局;然而,即使在共识指南发布后,关于抗癫痫药物的使用和依从性的文献仍然有限。
评估儿童 SE 中抗癫痫药物的使用情况,并分析遵守癫痫持续状态管理方案对临床结局的影响。
在一家三级教学医院进行了一项为期 8 个月的、针对 1 个月至 14 岁 SE 儿童的开放标签非随机前瞻性观察研究。评估了我们医院采用的癫痫持续状态管理方案中推荐的抗癫痫药物、药物给药顺序和管理时间框架的依从性。比较了依从性和不依从性患者的临床结局(住院时间、插管、难治性和超难治性 SE、SE 停止时间、运动功能障碍和认知下降)。
共有 40 名患者入组研究,其中 28 名(70%)为男孩。所有患者在分诊区均接受咪达唑仑鼻喷雾剂治疗。仅 18%的患者在院前环境中接受了抢救苯二氮䓬(BZD)抗癫痫药物(AED)治疗。一线 AED(BZD)和二线 AED(非 BZD)的首次给药中位时间(p-p)分别为 11(8-15)分钟和 30(22-35)分钟。连续输注(IV 咪达唑仑)的给药时间延迟至 57(45-69)分钟。24 名(60%)患者遵守了癫痫持续状态管理方案。治疗方案在时间框架方面的不依从显著延长了住院时间(9 天 vs 4 天,p=0.0008)和首次评估后的 SE 持续时间(115 分钟 vs 50 分钟;p=0.005)。出院时,依从组和不依从组患者的功能基线恢复比例差异有统计学意义(79% vs 44%)。无死亡病例。
院前环境中的抢救治疗需要引起重视。在选择 AED 和 AED 治疗顺序方面,完全遵守了癫痫持续状态管理方案。在时间框架内治疗管理的不依从显著影响住院时间、SE 持续时间和临床结局。